Showing 2161-2170 of 5643 results for "".
- Merck to Acquire EyeBio in a Deal Worth Up to $3 Billionhttps://modernod.com/news/merck-to-acquire-eyebio-in-a-deal-worth-up-to-3-billion/2482297/After a decade away, Merck will be re-entering the ophthalmology industry after agreeing to acquire privately-held Eyebiotech (EyeBio), maker of Restoret (EYE103), an investigational first-in-class treatment for retinal diseases. Under the terms of the dea
- Researchers Detail How Neurons Build a 3-D Vascular Structure to Keep the Retina Healthyhttps://modernod.com/news/researchers-detail-how-neurons-build-a-3-d-vascular-structure-to-keep-the-retina-healthy/2482292/Scientists have known for years that a lattice of blood vessels nourishes cells in the retina that allow us to see – but it’s been a mystery how the intricate structure is created. Now, researchers at University of California San Francisco have found a new type of neuron that guides i
- Topcon Healthcare Partners with Microsoft to Deliver AI-Powered ‘Healthcare from the Eye’https://modernod.com/news/topcon-healthcare-partners-with-microsoft-to-deliver-ai-powered-healthcare-from-the-eye/2482274/Topcon Healthcare announced a partnership with Microsoft Corporation to deliver AI-powered ‘Healthcare from the Eye’ solutions to improve healthcare access, cost, and quality. A cloud-based connected network of healthcare providers using the 'Nuance Precision I
- Safilo North America Appoints New Leaderhttps://modernod.com/news/safilo-north-america-appoints-new-leader/2482258/Safilo North America announced the appointment of Gabriele Cusani Sodano as president and chief commercial officer, effective April 2024. The company says Mr. Cusani brings a wealth of experience and a proven track record to succeed in this new role, which will focus on accelerating the implement
- iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaginghttps://modernod.com/news/ihealthscreen-awarded-us-patent-on-glaucoma-detection-based-on-ai-and-color-fundus-imaging/2482232/iHealthScreen was awarded a full US patent by USPTO on March 26, 2024 for the iPredict glaucoma detection model. The iPredict is designed to provide a fully automated detection report for glaucoma, which can be implemented in the primary care settings for screening and detecti
- First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgeryhttps://modernod.com/news/first-patient-enrolled-in-lynx-2-phase-3-study-evaluating-phentolamine-for-the-treatment-of-decreased-va-under-low-light-conditions-following-keratorefractive-surgery/2482227/Ocuphire Pharma announced the enrollment of the first subject in the LYNX-2 phase 3 registration study evaluating phentolamine ophthalmic solution 0.75% (PS) for the treatment of decreased visual acuity under low (mesopic) light conditions following keratorefractive surgery. The LY
- Oculis Appoints Snehal Shah, PharmD, as President of Research & Developmenthttps://modernod.com/news/oculis-appoints-snehal-shah-pharmd-as-president-of-research-development/2482225/Oculis announced the appointment of Snehal Shah, PharmD, executive leader with over two decades of research & development (R&D) and regulatory experience, to the role of President of R&D. In this new role, Dr. Shah will be responsible for leading research and developmen
- New VR Solution Aims to Democratize Ophthalmic Surgical Traininghttps://modernod.com/news/new-vr-solution-aims-to-democratize-ophthalmic-surgical-training/2482216/At the ASCRS annual meeting in Boston, Orbis International and FundamentalVR launched a new immersive virtual reality (VR) training solution designed for use in low- and middle-income countries. The tool is built to support students and residents learning to perform surgery to trea
- Alcon to Highlight New Data at ASCRS Demonstrating Innovations Designed to Optimize Patient Outcomeshttps://modernod.com/news/alcon-to-highlight-new-data-at-ascrs-demonstrating-innovations-designed-to-optimize-patient-outcomes/2482199/Alcon will showcase approximately 100 company-supported and investigator-led data presentations demonstrating its latest innovative efforts aimed at optimizing patient outcomes at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, April 5-8, in Boston. In additio
- Melt Pharmaceuticals Completes Stock Refinancing to Support Further Development of MELT-300https://modernod.com/news/melt-pharmaceuticals-completes-stock-refinancing-to-support-further-development-of-melt-300/2482198/Melt Pharmaceuticals announced the completion of its Series B Preferred Stock financing of approximately $24 million from new and existing investors. The capital raised will primarily support the further development of MELT-300, including the MELT-300 phase 3 program. MELT-300, a n